(Q53065417)

11 May 2018

title

Oversight of Marketing Relationships between Physicians and the Drug and Device Industry: A Comparative Study (English)

1 reference

https://api.crossref.org/works/10.1177/009885881003600203

20 June 2024

1

Timothy Stoltzfus Jost

1 reference

11 May 2018

author name string

Timothy Stoltzfus Jost

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20726399

20 June 2024

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=20726399

20 June 2024

publication date

1 January 2010

1 reference

11 May 2018

full work available at URL

http://journals.sagepub.com/doi/pdf/10.1177/009885881003600203

1 reference

https://api.crossref.org/works/10.1177/009885881003600203

https://www.cambridge.org/core/services/aop-cambridge-core/content/view/S0098858800001702

20 June 2024

1 reference

https://api.crossref.org/works/10.1177/009885881003600203

American Journal of Law and Medicine

20 June 2024

published in

1 reference

11 May 2018

volume

36

1 reference

11 May 2018

issue

2-3

1 reference

11 May 2018

page(s)

326-342

1 reference

11 May 2018

Perspectives on the pharmaceutical industry

cites work

1

1 reference

https://api.crossref.org/works/10.1177/009885881003600203

Characteristics and impact of drug detailing for gabapentin

20 June 2024

2

1 reference

https://api.crossref.org/works/10.1177/009885881003600203

The cost of pushing pills: a new estimate of pharmaceutical promotion expenditures in the United States

20 June 2024

3

1 reference

https://api.crossref.org/works/10.1177/009885881003600203

Estimating the cost of new drug development: is it really 802 million dollars?

20 June 2024

5

1 reference

https://api.crossref.org/works/10.1177/009885881003600203

Medical journals are an extension of the marketing arm of pharmaceutical companies

20 June 2024

6

1 reference

https://api.crossref.org/works/10.1177/009885881003600203

A social science perspective on gifts to physicians from industry

20 June 2024

7

1 reference

https://api.crossref.org/works/10.1177/009885881003600203

Scientists behaving badly

20 June 2024

9

1 reference

https://api.crossref.org/works/10.1177/009885881003600203

Gag clauses in clinical-trial agreements.

20 June 2024

10

1 reference

https://api.crossref.org/works/10.1177/009885881003600203

Off-label prescribing among office-based physicians

20 June 2024

12

1 reference

https://api.crossref.org/works/10.1177/009885881003600203

Scottish doctors will have to register financial links to drug companies

20 June 2024

13

1 reference

https://api.crossref.org/works/10.1177/009885881003600203

Doctors' education: the invisible influence of drug company sponsorship

20 June 2024

14

1 reference

https://api.crossref.org/works/10.1177/009885881003600203

The pipeline and the porcupine: alternate metaphors of the physician-industry relationship

20 June 2024

15

1 reference

https://api.crossref.org/works/10.1177/009885881003600203

Medical students' exposure to and attitudes about drug company interactions: a national survey.

20 June 2024

16

1 reference

https://api.crossref.org/works/10.1177/009885881003600203

Pharmaceutical promotion to physicians and First Amendment rights

20 June 2024

17

1 reference

https://api.crossref.org/works/10.1177/009885881003600203

Failing the public health--rofecoxib, Merck, and the FDA.

20 June 2024

18

1 reference

https://api.crossref.org/works/10.1177/009885881003600203

Curbing the influence of the drug industry: a British view

20 June 2024

19

1 reference

https://api.crossref.org/works/10.1177/009885881003600203

Selling sickness: the pharmaceutical industry and disease mongering

20 June 2024

20

1 reference

https://api.crossref.org/works/10.1177/009885881003600203

Surviving sepsis--practice guidelines, marketing campaigns, and Eli Lilly

20 June 2024

21

1 reference

https://api.crossref.org/works/10.1177/009885881003600203

All gifts large and small: toward an understanding of the ethics of pharmaceutical industry gift-giving.

20 June 2024

22

1 reference

https://api.crossref.org/works/10.1177/009885881003600203

Leopards in the temple: restoring scientific integrity to the commercialized research scene

20 June 2024

23

1 reference

https://api.crossref.org/works/10.1177/009885881003600203

Survey of unlicensed and off label drug use in paediatric wards in European countries. European Network for Drug Investigation in Children

20 June 2024

24

1 reference

https://api.crossref.org/works/10.1177/009885881003600203

How to dance with porcupines: rules and guidelines on doctors' relations with drug companies

20 June 2024

25

1 reference

https://api.crossref.org/works/10.1177/009885881003600203

20 June 2024

Identifiers

1 reference

11 May 2018

1 reference

11 May 2018